Sana Biotechnology, Inc. Financials
SANA
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 ~12.8:1 split |
|---|---|---|---|---|---|
| General & Administrative | $44 | $64 | $73 | $72 | $50 |
| Research & Development | $132 | $216 | $262 | $286 | $249 |
| Total Operating Expenses | $250 | $273 | $293 | $273 | $357 |
| Operating Income | -$250 | -$273 | -$293 | -$273 | -$357 |
| Other Non-Operating Income (Expense) | $2 | -$5 | -$0 | -$1 | $0 |
| EBT (Earnings Before Tax) | – | – | – | – | -$356 |
| Income Tax Expense | $0 | – | – | – | – |
| Net Income | |||||
| Net Income | -$244 | -$267 | -$283 | -$269 | -$356 |
| EPS (Basic) | -$0.96 | -$1.16 | -$1.46 | -$1.43 | -$2.14 |
| EPS (Diluted) | -$0.96 | -$1.16 | -$1.46 | -$1.43 | -$2.14 |
| Weighted Avg Shares (Basic) | 253.2M | 230.9M | 194.5M | 188.3M | 166.4M |
| Weighted Avg Shares (Diluted) | 253.2M | 230.9M | 194.5M | 188.3M | 166.4M |
| Shares Outstanding | 253.2M | 230.9M | 194.5M | 188.3M | 166.4M |
Sana Biotechnology (SANA) financials: revenue, profit and margins
Sana Biotechnology (SANA) generated about n/a in revenue and -$149 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
Is Sana Biotechnology profitable?+
Sana Biotechnology reported about -$149 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
SourceFinancial statements computed from the 10-Q filed 29 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 6 Nov 2026. How this is calculated.
Fiscal year ends Dec.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SANA
Held by ETFs
SANA is in 18 US ETFs. The largest of them, with SANA's weight in each:
Vanguard Health Care ETFVHT0.01%of the fund
iShares Russell 2000 Growth ETFIWO0.03%of the fund
Fidelity Nasdaq Composite Index ETFONEQ0.00%of the fund
State Street SPDR S&P Biotech ETFXBI0.14%of the fund
iShares Biotechnology ETFIBB0.03%of the fund
iShares U.S. Small-Cap Equity Factor ETFSMLF0.04%of the fund
Spot a number that looks wrong? Check it in SANA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SANA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.